The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
about
Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimersPhosphorylated α-synuclein in Parkinson's disease.Parkinson's disease: from molecular pathways in disease to therapeutic approaches.Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activitiesLRRK2 in Parkinson's disease: function in cells and neurodegeneration.
P2860
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@en
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@nl
type
label
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@en
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@nl
altLabel
The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease
@en
prefLabel
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@en
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@nl
P2860
P356
P1476
The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.
@en
P2093
Saurabh Sen
P2860
P304
P356
10.1089/ARS.2009.2430
P577
2009-09-01T00:00:00Z